ethoglucid has been researched along with Carcinoma, Intraepithelial in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lum, BL | 1 |
| Fitzpatrick, JM; Khan, O; Oliver, RT; Riddle, PR | 1 |
| Duque, JL; Loughlin, KR | 1 |
| Lum, BL; Torti, FM | 1 |
3 review(s) available for ethoglucid and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Epirubicin; Ethoglucid; Humans; Immunotherapy; Mitomycin; Thiotepa; Urinary Bladder Neoplasms | 2000 |
Therapeutic approaches including interferon to carcinoma in situ of the bladder.
Topics: Administration, Topical; BCG Vaccine; Carcinoma in Situ; Cyclophosphamide; Doxorubicin; Ethoglucid; Humans; Interferons; Mitomycins; Papilloma; Thiotepa; Urinary Bladder Neoplasms | 1985 |
1 other study(ies) available for ethoglucid and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Prognostic factors influencing survival of patients receiving intravesical epodyl.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Drug Administration Schedule; Ethers; Ethoglucid; Humans; Neoplasm Recurrence, Local; Retrospective Studies; Urinary Bladder Neoplasms | 1982 |